Literature DB >> 67588

Hepatitis B antigen in the liver cells in cirrhosis and hepatocellular carcinoma.

A Y Tan, C H Law, Y S Lee.   

Abstract

The demonstration of hepatitis B antigen in the liver cells in formalin fixed paraffin embedded tissues by Shikata's orcein staining method affords an opportunity to conduct retrospective studies on necrospy materials. Such a study in Singapore showed orcein-positive liver cells in 22 out of 52 (42.3%) and 37 out of 50 (74.0%) cases of cirrhosis of the liver and hepatocellular carcinoma respectively, while only 5 out of 113 (4.4%) 'normal' livers gave positive results. There is a significant difference in the frequency of hepatocellular carcinoma in orcein-positive and orcein-negative cirrhotic livers (28 out of 50, 10 out of 40 respectively). These results suggest a possible aetiological relationship between hepatitis B antigen and hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 67588     DOI: 10.3109/00313027709085239

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  4 in total

1.  The epidemiology of primary liver cancer in a West German population: the Saarland.

Authors:  K Rimkus; G Dhom
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  Chronic hepatitis B infection and liver cancer.

Authors:  Ch Wong; Kl Goh
Journal:  Biomed Imaging Interv J       Date:  2006-07-01

3.  Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma.

Authors:  M C Kew; M B Ray; V J Desmet; J Desmyter
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

4.  Comparative study of hepatocellular carcinoma in Shikoku, Japan: a study of 198 autopsy cases in Tokushima and Ehime Prefectures.

Authors:  G Akagi; K Furuya; H Otsuka; S Tao; S Moriwaki
Journal:  Jpn J Cancer Res       Date:  1988-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.